GOSS News

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Lost Money on Gossamer Bio, Inc. (GOSS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026

Pomerantz LLP Shares Class Action Details With Shareholders in Gossamer Bio, Inc. – GOSS

GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Gossamer Bio, Inc. to Contact the Firm Today!

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

GOSS Investor Alert: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm